Concentra Group Holdings Parent, Inc. (NYSE: CON), a leader in occupational health services with a market capitalization of $2.84 billion, has announced preliminary financial results for the fourth ...

Concentra Announces Preliminary 2024 Financial Results, Agreement To Acquire Nova Medical Centers, and 2025 Financial Guidance ...

(Bloomberg) -- Nova Biomedical is exploring a potential sale that could value it at more than $2 billion, people with knowledge of the matter said. The privately-held medical device maker is ...

The Nova Primary blood glucose reference analyzer meets the requirements of glucose device manufacturers and clinical researchers for an accurate, user-friendly replacement for the discontinued ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Nova Eye Medical Limited (EYE). However, you won't necessarily see their names in the company’s ...